Israeli startup SoniVie has a novel system for the treatment of pulmonary arterial hypertension, a progressive and fatal illness with no current cure. SoniVie has just successfully completed the first two procedures for its First In Human (FIH) multi-center clinical trial.
Treatment for Pulmonary Arterial Hypertension
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.